Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Change in Receivables (2016 - 2022)

Aethlon Medical filings provide 10 years of Change in Receivables readings, the most recent being -$114849.0 for Q4 2022.

  • On a quarterly basis, Change in Receivables changed N/A to -$114849.0 in Q4 2022 year-over-year; TTM through Sep 2023 was -$114849.0, a 570.96% decrease, with the full-year FY2023 number at -$127965.0, down 505.98% from a year prior.
  • Change in Receivables hit -$114849.0 in Q4 2022 for Aethlon Medical, down from -$13116.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $206729.0 in Q4 2019 to a low of -$114849.0 in Q4 2022.
  • Median Change in Receivables over the past 5 years was -$4001.0 (2022), compared with a mean of $8312.6.
  • The widest YoY moves for Change in Receivables: up 23.37% in 2022, down 111.69% in 2022.
  • Aethlon Medical's Change in Receivables stood at $74813.0 in 2018, then soared by 176.33% to $206729.0 in 2019, then plummeted by 98.55% to $3000.0 in 2020, then tumbled by 670.53% to -$17116.0 in 2021, then plummeted by 571.0% to -$114849.0 in 2022.
  • The last three reported values for Change in Receivables were -$114849.0 (Q4 2022), -$13116.0 (Q2 2022), and -$4001.0 (Q1 2022) per Business Quant data.